Locate providers:   

FDA-approved LATISSE Lash Enhancer Now Available at The Skin Center Medical Spa


New FDA-approved Product increases length, thickness and darkness of eyelashes.

Pittsburgh, PA (PRWEB) February 9, 2009 - A new FDA-approved cosmetic product, LATISSE, designed to lengthen, strengthen and darken eyelashes is now available at The Skin Center Medical Spa with locations in Pittsburgh, PA and Columbus, Ohio.

LATISSE, developed by Allergan, the makers of BOTOX Cosmetic, is the first and only science-based treatment approved by the FDA to enhance eyelash prominence as measured by increases in length, thickness and darkness of eyelashes.

The Skin Center Medical Spa will incorporate LATISSE into its exclusive EyeQ treatment which is a minimally-invasive eye enhancement breakthrough designed to refresh and rejuvenate tired or older eyes by eliminating wrinkles, the appearance of under eye circles and fat pads in just one quick office visit.

EyeQ incorporates the use of BOTOX Cosmetic, injectable wrinkle fillers and topical treatments such as LATISSE to create a customized rejuvenation treatment based on the individual needs of each client.

"LATISSE is a tremendous breakthrough for the revitalization of brittle, weak and short lashes," said Dr. Dominic A. Brandy, board-certified cosmetic surgeon and founding medical director of The Skin Center Medical Spa.

"This product actually promotes new growth and lash thickening, which is very unique. Similar products on the market only impact existing lashes, this is the first product to actually enhance lash growth which is a very desirable quality for a youthful eye area."

Now available at The Skin Center Medical Spa, LATISSE is a once-daily prescription treatment applied to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator.

LATISSE users can expect to experience longer, fuller and darker eyelashes in as little as eight weeks, with full results in 16 weeks. To maintain effect, continued treatment with LATISSE is required.

If use of LATISSE is discontinued, eyelashes will gradually return to where they were prior to treatment over a period of weeks to months (average eyelash hair cycle).

The LATISSE Bimatoprost is the active pharmaceutical ingredient in the formulation of LATISSE and is a structural prostaglandin analog, which is a lipid compound derived from fatty acids designed to bind to prostaglandin (PG) receptors.

PG receptors are present in hair, particularly in the dermal papilla and outer root sheath.

Although the precise mechanism of action is unknown, PG receptors are thought to be involved in the development and regrowth of the hair follicle, by increasing the percent of hairs in, and the duration of, the anagen or growth phase.

LATISSE is available in the United States through a physician's office only and is subject to all U.S. guidelines applicable to dispensing a prescription product.

The Skin Center Medical Spa, located in Pennsylvania and Ohio, is the region's premier, full-service medical spa offering the latest advancements in non-invasive and minimally invasive skin rejuvenation for the treatment of aging skin, hyper-pigmentation, rosacea, unwanted hair, varicose and spider veins, active acne and acne scarring.

The Skin Center Medical Spa was founded in 1981 in Pittsburgh, PA, by Dominic Brandy, MD, board-certified cosmetic surgeon.

For more information about LATISSE, contact The Skin Center Medical Spa at 1-800-429-1151.